| Date Filed | Type | Description |
| 06/16/2023 |
4
| Powell Lynne (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Granted 12,500 shares
@ $0
Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
| 01/05/2023 |
4
| Powell Lynne (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 45 shares
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Powell Lynne (Director) has filed a Form 3 on PROGENITY, INC. |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $9.4, valued at
$18.8k
Exercised 2,000 options to buy
@ $3.22, valued at
$6.4k
|
|
| 01/18/2019 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 3,046 shares
@ $9.27, valued at
$28.2k
Exercised 3,046 options to buy
@ $3.22, valued at
$9.8k
|
|
| 01/16/2019 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 954 shares
@ $9.2, valued at
$8.8k
Exercised 954 options to buy
@ $3.22, valued at
$3.1k
|
|
| 12/21/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 190,000 options to buy
@ $7.06, valued at
$1.3M
|
|
| 12/12/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $9.01, valued at
$18k
Sold 2,000 shares
@ $9.11, valued at
$18.2k
Exercised 2,000 options to buy
@ $3.22, valued at
$6.4k
|
|
| 11/26/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 12,000 shares
@ $9.06, valued at
$108.7k
Sold 2,455 shares
@ $9.01, valued at
$22.1k
Exercised 12,000 options to buy
@ $3.22, valued at
$38.6k
|
|
| 11/21/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 193 shares
@ $8.3, valued at
$1.6k
Sold 9,127 shares
@ $8.52, valued at
$77.8k
Sold 6,150 shares
@ $8.61, valued at
$53k
Exercised 193 options to buy
@ $3.22, valued at
$621.5
Exercised 9,127 options to buy
@ $3.22, valued at
$29.4k
|
|
| 11/09/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 300 shares
@ $8, valued at
$2.4k
Sold 5,280 shares
@ $8.15, valued at
$43k
Exercised 300 options to buy
@ $3.22, valued at
$966
Exercised 5,280 options to buy
@ $3.22, valued at
$17k
|
|
| 11/07/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 100 shares
@ $8, valued at
$800
Exercised 100 options to buy
@ $3.22, valued at
$322 |
|
| 11/06/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $8, valued at
$8k
Exercised 1,000 options to buy
@ $3.22, valued at
$3.2k
|
|
| 11/05/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 1,544 shares
@ $7.51, valued at
$11.6k
|
|
| 10/23/2018 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 100 shares
@ $7.5, valued at
$750 |
|
| 12/22/2017 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options to buy
@ $5.04, valued at
$403.2k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2016 |
4
| Powell Lynne (Senior VP - CCO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 129,427 options to buy
@ $3.22, valued at
$416.8k
|
|